{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:08:42Z","timestamp":1759018122809,"version":"3.44.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12223-025-01303-2","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T05:34:10Z","timestamp":1753248850000},"page":"739-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanobodies: a new frontier in influenza virus neutralization"],"prefix":"10.1007","volume":"70","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed K.","family":"Abdulsahib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok Kumar","family":"Bishoyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhas","family":"Ballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhayveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khasankhodja","family":"Abidov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal Kant","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munther","family":"Kadheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manizhe","family":"Jozpanahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Darvishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"1303_CR1","doi-asserted-by":"publisher","first-page":"1026951","DOI":"10.3389\/fimmu.2022.1026951","volume":"13","author":"A Aartse","year":"2022","unstructured":"Aartse A, Mortier D, Mooij P, Hofman S, van Haaren MM, Corcoran M et al (2022) Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies. Front Immunol 13:1026951","journal-title":"Front Immunol"},{"issue":"1","key":"1303_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","volume":"22","author":"E Alexander","year":"2024","unstructured":"Alexander E, Leong KW (2024) Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years. Journal of Nanobiotechnology 22(1):661","journal-title":"Journal of Nanobiotechnology"},{"issue":"5","key":"1303_CR3","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1128\/JVI.02693-14","volume":"89","author":"J Ashour","year":"2015","unstructured":"Ashour J, Schmidt FI, Hanke L, Cragnolini J, Cavallari M, Altenburg A et al (2015) Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization. J Virol 89(5):2792\u20132800","journal-title":"J Virol"},{"key":"1303_CR4","doi-asserted-by":"publisher","unstructured":"Bai Y, Jones JC, Wong S\u2011S, Zanin M. Antivirals targeting the surface glycoproteins of influenza virus: mechanisms of action and resistance. Viruses. 2021 Apr 6;13(4):624. https:\/\/doi.org\/10.3390\/v13040624.","DOI":"10.3390\/v13040624"},{"issue":"7","key":"1303_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301664","volume":"19","author":"ES Barbieri","year":"2024","unstructured":"Barbieri ES, Sosa-Holt C, Iba\u00f1ez LI, Baztarrica J, Garaicoechea L, Gay CL et al (2024) Anti-hemagglutinin monomeric nanobody provides prophylactic immunity against H1 subtype influenza A viruses. PLoS ONE 19(7):e0301664","journal-title":"PLoS ONE"},{"key":"1303_CR6","unstructured":"Bessonne M (2023) D\u00e9veloppement et caract\u00e9risation fonctionnelle de nanoligands sp\u00e9cifiques de l'ARN polym\u00e9rase des virus Influenza: Universit\u00e9 Paris-Saclay"},{"issue":"6","key":"1303_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011642","volume":"20","author":"M Bessonne","year":"2024","unstructured":"Bessonne M, Morel J, Nevers Q, Da Costa B, Ballandras-Colas A, Chenavier F et al (2024) Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase core. PLoS Pathog 20(6):e1011642","journal-title":"PLoS Pathog"},{"key":"1303_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijbiomac.2022.12.284","volume":"229","author":"M Bhattacharya","year":"2023","unstructured":"Bhattacharya M, Chatterjee S, Lee S-S, Chakraborty C (2023) Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: current update. Int J Biol Macromol 229:70\u201380","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"1303_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0022-2836(03)00967-7","volume":"332","author":"CJ Bond","year":"2003","unstructured":"Bond CJ, Marsters JC Jr, Sidhu SS (2003) Contributions of CDR3 to VHH domain stability and the design of monobody scaffolds for naive antibody libraries. J Mol Biol 332(3):643\u2013655","journal-title":"J Mol Biol"},{"key":"1303_CR10","doi-asserted-by":"crossref","unstructured":"Broadbent L, Parke HG, Ferguson LJ, Millar A, Shields MD, Detalle L et al (2020) Comparative therapeutic potential of ALX-0171 and palivizumab against respiratory syncytial virus clinical isolate infection of well-differentiated primary pediatric bronchial epithelial cell cultures.\u00a0Antimicrob Agents Chemother 64(2).\u00a0https:\/\/doi.org\/10.1128\/aac.02034\u201319","DOI":"10.1128\/AAC.02034-19"},{"issue":"1","key":"1303_CR11","doi-asserted-by":"publisher","first-page":"15899","DOI":"10.1038\/s41598-019-52258-7","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao J, Zhong N, Wang G, Wang M, Zhang B, Fu B et al (2019) Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection. Sci Rep 9(1):15899","journal-title":"Sci Rep"},{"issue":"15","key":"1303_CR12","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1128\/JVI.03178-13","volume":"88","author":"FM Cardoso","year":"2014","unstructured":"Cardoso FM, Iba\u00f1ez LI, Van den Hoecke S, De Baets S, Smet A, Roose K et al (2014) Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge. J Virol 88(15):8278\u20138296","journal-title":"J Virol"},{"key":"1303_CR13","unstructured":"Centers for Disease Control and Prevention. 2024\u20132025 influenza burden data visualization [Internet]. Atlanta: CDC; 2025 [cited 2025 Jul 20]. Available from: https:\/\/www.cdc.gov\/flu-burden\/php\/data-vis\/2024-2025.html."},{"key":"1303_CR14","doi-asserted-by":"crossref","unstructured":"Chabrol E, Stojko J, Nicolas A, Botzanowski T, Fould B, Antoine M et al (2020) VHH characterization. Recombinant VHHs: production, characterization and affinity.\u00a0Anal Biochem 589:113491","DOI":"10.1016\/j.ab.2019.113491"},{"key":"1303_CR15","doi-asserted-by":"publisher","unstructured":"Chames P, Rothbauer U. Special Issue: Nanobody. Antibodies. 2020 Mar 6;9(1):6. https:\/\/doi.org\/10.3390\/antib9010006.","DOI":"10.3390\/antib9010006"},{"key":"1303_CR16","doi-asserted-by":"crossref","unstructured":"Chen Y-Q, Wohlbold TJ, Zheng N-Y, Huang M, Huang Y, Neu KE et al (2018) Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173(2):417\u201329.e10","DOI":"10.1016\/j.cell.2018.03.030"},{"issue":"1","key":"1303_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41467-024-55193-y","volume":"16","author":"Z-S Chen","year":"2025","unstructured":"Chen Z-S, Huang H-C, Wang X, Sch\u00f6n K, Jia Y, Lebens M et al (2025) Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection. Nat Commun 16(1):432","journal-title":"Nat Commun"},{"issue":"2","key":"1303_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/cancers16020371","volume":"16","author":"Y Cong","year":"2024","unstructured":"Cong Y, Devoogdt N, Lambin P, Dubois LJ, Yaromina A (2024) Promising diagnostic and therapeutic approaches based on VHHs for cancer management. Cancers 16(2):371","journal-title":"Cancers"},{"issue":"1","key":"1303_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","volume":"24","author":"L Coughlan","year":"2018","unstructured":"Coughlan L, Palese P (2018) Overcoming barriers in the path to a universal influenza virus vaccine. Cell Host Microbe 24(1):18\u201324","journal-title":"Cell Host Microbe"},{"issue":"4","key":"1303_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.vaccine.2005.07.096","volume":"24","author":"SR Crowe","year":"2006","unstructured":"Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, Harmsen AG et al (2006) Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24(4):457\u2013467","journal-title":"Vaccine"},{"issue":"6","key":"1303_CR21","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.4049\/jimmunol.171.6.3163","volume":"171","author":"NA Danke","year":"2003","unstructured":"Danke NA, Kwok WW (2003) HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 171(6):3163\u20133169","journal-title":"J Immunol"},{"key":"1303_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-015-0320-7","volume":"14","author":"A De Marco","year":"2015","unstructured":"De Marco A (2015) Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs. Microb Cell Fact 14:1\u201317","journal-title":"Microb Cell Fact"},{"key":"1303_CR23","doi-asserted-by":"publisher","first-page":"1334829","DOI":"10.3389\/fimmu.2024.1334829","volume":"15","author":"H De Greve","year":"2024","unstructured":"De Greve H, Fioravanti A (2024) Single domain antibodies from camelids in the treatment of microbial infections. Front Immunol 15:1334829","journal-title":"Front Immunol"},{"issue":"1","key":"1303_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antib8010001","volume":"8","author":"D De Vlieger","year":"2018","unstructured":"De Vlieger D, Ballegeer M, Rossey I, Schepens B, Saelens X (2018) Single-domain antibodies and their formatting to combat viral infections. Antibodies 8(1):1","journal-title":"Antibodies"},{"key":"1303_CR25","doi-asserted-by":"crossref","unstructured":"Delmas B, Bessonne M, Morel J, Minard P. Inhibition of influenza virus replication by artificial proteins (\u03b1Reps) targeting its RNA\u2011polymerase [preprint]. Jul 2024. Available from:https:\/\/www.researchgate.net\/publication\/268793052_Structure_of_influenza_A_polymerase_bound_to_the_viral_RNA_promoter","DOI":"10.1101\/2024.07.03.601934"},{"key":"1303_CR26","unstructured":"Del Rosario JMM (2020) Immunoprophylaxis of influenza using AAV vector delivery of cross-subtype neutralizing nanobodies: UCL (University College London)"},{"key":"1303_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2020.00627","volume":"11","author":"JMM Del Rosario","year":"2020","unstructured":"Del Rosario JMM, Smith M, Zaki K, Risley P, Temperton N, Engelhardt OG et al (2020a) Protection from influenza by intramuscular gene vector delivery of a broadly neutralizing nanobody does not depend on antibody dependent cellular cytotoxicity. Front Immunol 11:627","journal-title":"Front Immunol"},{"issue":"11","key":"1303_CR28","first-page":"1","volume":"2020","author":"J Del Rosario","year":"2020","unstructured":"Del Rosario J, Smith M, Zaki K, Risley P, Temperton N, Engelhardt O (2020b) Protection from influenza by intramuscular gene vector delivery of a broadly neutralizing nanobody does not depend on antibody dependent cellular cytotoxicity. Front Immunol 2020(11):1\u201315","journal-title":"Front Immunol"},{"issue":"7417","key":"1303_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R et al (2012) Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489(7417):526\u2013532","journal-title":"Nature"},{"issue":"23","key":"1303_CR30","doi-asserted-by":"publisher","first-page":"7237","DOI":"10.1007\/s00018-021-03957-w","volume":"78","author":"E Elshina","year":"2021","unstructured":"Elshina E, Te Velthuis AJ (2021) The influenza virus RNA polymerase as an innate immune agonist and antagonist. Cell Mol Life Sci 78(23):7237\u20137256","journal-title":"Cell Mol Life Sci"},{"issue":"7773","key":"1303_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41586-019-1530-7","volume":"573","author":"H Fan","year":"2019","unstructured":"Fan H, Walker AP, Carrique L, Keown JR, Martin IS, Karia D et al (2019) Influenza A virus RNA polymerase structures provide insights into viral genome replication. Nature 573(7773):287","journal-title":"Nature"},{"issue":"9","key":"1303_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038398","volume":"10","author":"E Fodor","year":"2020","unstructured":"Fodor E, Te Velthuis AJ (2020) Structure and function of the influenza virus transcription and replication machinery. Cold Spring Harb Perspect Med 10(9):a038398","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"1303_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164296","volume":"11","author":"T Gaiotto","year":"2016","unstructured":"Gaiotto T, Hufton SE (2016) Cross-neutralising nanobodies bind to a conserved pocket in the hemagglutinin stem region identified using yeast display and deep mutational scanning. PLoS ONE 11(10):e0164296","journal-title":"PLoS ONE"},{"key":"1303_CR34","doi-asserted-by":"crossref","unstructured":"Galloway SE, Liang B, Steinhauer DA (2018) Activation of the hemagglutinin of influenza viruses. Activation of viruses by host proteases 3\u201326","DOI":"10.1007\/978-3-319-75474-1_1"},{"issue":"20","key":"1303_CR35","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","volume":"368","author":"R Gao","year":"2013","unstructured":"Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W et al (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368(20):1888\u20131897","journal-title":"N Engl J Med"},{"key":"1303_CR36","unstructured":"Georges S-L (2019) Therapeutic and diagnostic nanobodies and their application in veterinary medicine: Ghent University"},{"key":"1303_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6750-12-59","volume":"12","author":"S G\u00f3mez-Sebasti\u00e1n","year":"2012","unstructured":"G\u00f3mez-Sebasti\u00e1n S, Nu\u00f1ez MC, Garaicoechea L, Alvarado C, Mozgovoj M, Lasa R et al (2012) Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo. BMC Biotechnol 12:1\u201311","journal-title":"BMC Biotechnol"},{"key":"1303_CR38","doi-asserted-by":"crossref","unstructured":"Hanke L, Knockenhauer KE, Brewer RC, van Diest E, Schmidt FI, Schwartz TU et al (2016) The antiviral mechanism of an influenza A virus nucleoprotein-specific single-domain antibody fragment. MBio 7(6).\u00a0https:\/\/doi.org\/10.1128\/mbio.01569\u201316","DOI":"10.1128\/mBio.01569-16"},{"key":"1303_CR39","doi-asserted-by":"publisher","unstructured":"Harmsen MM, de Smit H. Serum immunoglobulin or albumin binding single\u2011domain antibodies that enable tailored half\u2011life extension of biologics in multiple animal species. Front Immunol. 2024;15:1346328. https:\/\/doi.org\/10.3389\/fimmu.2024.1346328.","DOI":"10.3389\/fimmu.2024.1346328"},{"issue":"5","key":"1303_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1083\/jcb.201409074","volume":"209","author":"J Helma","year":"2015","unstructured":"Helma J, Cardoso MC, Muyldermans S, Leonhardt H (2015) Nanobodies and recombinant binders in cell biology. J Cell Biol 209(5):633\u2013644","journal-title":"J Cell Biol"},{"issue":"9885","key":"1303_CR41","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(13)61125-3","volume":"381","author":"Y Hu","year":"2013","unstructured":"Hu Y, Lu S, Song Z, Wang W, Hao P, Li J et al (2013) Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. The Lancet 381(9885):2273\u20132279","journal-title":"The Lancet"},{"issue":"1","key":"1303_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ddr.21895","volume":"83","author":"S Hu","year":"2022","unstructured":"Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T (2022) Races of small molecule clinical trials for the treatment of COVID-19: an up-to-date comprehensive review. Drug Dev Res 83(1):16\u201354","journal-title":"Drug Dev Res"},{"key":"1303_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131458","volume":"267","author":"X Huang","year":"2024","unstructured":"Huang X, Li W, Cao X, Zhang Q, Lin Y, Xu S et al (2024) Generation and characterization of a nanobody against the avian influenza virus H7 subtype. Int J Biol Macromol 267:131458","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"1303_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103294","volume":"9","author":"SE Hufton","year":"2014","unstructured":"Hufton SE, Risley P, Ball CR, Major D, Engelhardt OG, Poole S (2014) The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency. PLoS ONE 9(8):e103294","journal-title":"PLoS ONE"},{"issue":"8","key":"1303_CR45","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","volume":"203","author":"LI Ibanez","year":"2011","unstructured":"Ibanez LI, De Filette M, Hultberg A, Verrips T, Temperton N, Weiss RA et al (2011) Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J Infect Dis 203(8):1063\u20131072","journal-title":"J Infect Dis"},{"key":"1303_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104780","volume":"178","author":"PH Jalily","year":"2020","unstructured":"Jalily PH, Duncan MC, Fedida D, Wang J, Tietjen I (2020) Put a cork in it: plugging the M2 viral ion channel to sink influenza. Antiviral Res 178:104780","journal-title":"Antiviral Res"},{"issue":"5","key":"1303_CR47","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/biom15050610","volume":"15","author":"W Jiang","year":"2025","unstructured":"Jiang W, Huang C, Muyldermans S, Jia L (2025) Small but mighty: nanobodies in the fight against infectious diseases. Biomolecules 15(5):610","journal-title":"Biomolecules"},{"key":"1303_CR48","doi-asserted-by":"publisher","first-page":"1086297","DOI":"10.3389\/fimmu.2023.1086297","volume":"14","author":"C Jiao","year":"2023","unstructured":"Jiao C, Wang B, Chen P, Jiang Y, Liu J (2023) Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses. Front Immunol 14:1086297","journal-title":"Front Immunol"},{"issue":"1","key":"1303_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41467-021-27950-w","volume":"13","author":"JR Keown","year":"2022","unstructured":"Keown JR, Zhu Z, Carrique L, Fan H, Walker AP, Serna Martin I et al (2022) Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies. Nat Commun 13(1):251","journal-title":"Nat Commun"},{"key":"1303_CR50","doi-asserted-by":"crossref","unstructured":"Kitamura S, Lin T-H, Lee C-CD, Takamura A, Kadam RU, Zhang D et al (2024) Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences 121(22):e2310677121.","DOI":"10.1073\/pnas.2310677121"},{"key":"1303_CR51","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3389\/fimmu.2020.01531","volume":"11","author":"R Konwarh","year":"2020","unstructured":"Konwarh R (2020) Nanobodies: prospects of expanding the gamut of neutralizing antibodies against the novel coronavirus, SARS-CoV-2. Front Immunol 11:1531","journal-title":"Front Immunol"},{"issue":"17","key":"1303_CR52","doi-asserted-by":"publisher","first-page":"13229","DOI":"10.3390\/ijms241713229","volume":"24","author":"S Kunz","year":"2023","unstructured":"Kunz S, Durandy M, Seguin L, Feral CC (2023) NANOBODY\u00ae molecule, a giga medical tool in nanodimensions. Int J Mol Sci 24(17):13229","journal-title":"Int J Mol Sci"},{"key":"1303_CR53","unstructured":"Landman A, Pascha M, de Haan X. Improving binding breadth and potency of NA-targeting nanobodies by multivalency. Final report. Utrecht: Virology Group, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University; 2024."},{"issue":"6","key":"1303_CR54","first-page":"415","volume":"17","author":"M Lazniewski","year":"2018","unstructured":"Lazniewski M, Dawson WK, Szczepi\u0144ska T, Plewczynski D (2018) The structural variability of the influenza A hemagglutinin receptor-binding site. Brief Funct Genomics 17(6):415\u2013427","journal-title":"Brief Funct Genomics"},{"key":"1303_CR55","doi-asserted-by":"crossref","unstructured":"Li X-F, Zhang Y-J, Yao Y-L, Chen M-X, Wang L-L, Wang M-D et al (2024) The association of post\u2013embryo transfer SARS-CoV-2 infection with early pregnancy outcomes in in vitro fertilization: a prospective cohort study. Am J Obstet Gynecol 230(4):436. e1-e12","DOI":"10.1016\/j.ajog.2023.12.022"},{"key":"1303_CR56","doi-asserted-by":"crossref","unstructured":"Liu X, Balligand T, Carpenet C, Ploegh HL (2023) An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections.\u00a0Sci Immunol 8(84):eadg9459","DOI":"10.1126\/sciimmunol.adg9459"},{"key":"1303_CR57","doi-asserted-by":"publisher","first-page":"1059771","DOI":"10.3389\/fimmu.2022.1059771","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, Lin H, Cao L, Wang K, Sui J (2022) Research progress on unique paratope structure, antigen binding modes, and systematic mutagenesis strategies of single-domain antibodies. Front Immunol 13:1059771","journal-title":"Front Immunol"},{"issue":"8","key":"1303_CR58","doi-asserted-by":"publisher","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","volume":"145","author":"TC Luke","year":"2006","unstructured":"Luke TC, Kilbane EM, Jackson JL, Hoffman SL (2006) Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 145(8):599\u2013609","journal-title":"Ann Intern Med"},{"key":"1303_CR59","doi-asserted-by":"crossref","unstructured":"Luo M. Influenza virus entry. In: Rossmann MG, Rao VB, editors. Viral Molecular Machines. Vol. 726. Berlin: Springer; 2012. p.\u202f201\u201321. https:\/\/doi.org\/10.1007\/978\u20111\u20114614\u20110980\u20119_9","DOI":"10.1007\/978-1-4614-0980-9_9"},{"key":"1303_CR60","doi-asserted-by":"crossref","unstructured":"Mair CM, Ludwig K, Herrmann A, Sieben C (2014) Receptor binding and pH stability\u2014how influenza A virus hemagglutinin affects host-specific virus infection.\u00a0Biochim Biophys Acta Biomembr 1838(4):1153\u201368","DOI":"10.1016\/j.bbamem.2013.10.004"},{"key":"1303_CR61","doi-asserted-by":"crossref","unstructured":"Matthys A, Saelens X (2024) Promises and challenges of single-domain antibodies to control influenza.\u00a0Antivir Res 105807","DOI":"10.1016\/j.antiviral.2024.105807"},{"issue":"2","key":"1303_CR62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3111\/13696998.2012.752376","volume":"16","author":"J Mauskopf","year":"2013","unstructured":"Mauskopf J, Klesse M, Lee S, Herrera-Taracena G (2013) The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ 16(2):264\u2013277","journal-title":"J Med Econ"},{"key":"1303_CR63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","volume":"10","author":"JL McAuley","year":"2019","unstructured":"McAuley JL, Gilbertson BP, Trifkovic S, Brown LE, McKimm-Breschkin JL (2019) Influenza virus neuraminidase structure and functions. Front Microbiol 10:39","journal-title":"Front Microbiol"},{"issue":"1","key":"1303_CR64","doi-asserted-by":"publisher","first-page":"e01070","DOI":"10.1128\/jvi.01070-22","volume":"97","author":"P Meade","year":"2023","unstructured":"Meade P, Strohmeier S, Berm\u00fadez-Gonz\u00e1lez MC, Garc\u00eda-Sastre A, Palese P, Simon V et al (2023) Antigenic landscape analysis of individuals vaccinated with a universal influenza virus vaccine candidate reveals induction of cross-subtype immunity. J Virol 97(1):e01070-e1122","journal-title":"J Virol"},{"key":"1303_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104619","volume":"134","author":"A Messer","year":"2020","unstructured":"Messer A, Butler DC (2020) Optimizing intracellular antibodies (intrabodies\/nanobodies) to treat neurodegenerative disorders. Neurobiol Dis 134:104619","journal-title":"Neurobiol Dis"},{"key":"1303_CR66","doi-asserted-by":"publisher","first-page":"1303353","DOI":"10.3389\/fimmu.2023.1303353","volume":"14","author":"VM Minatel","year":"2024","unstructured":"Minatel VM, Prudencio CR, Barraviera B, Ferreira RS Jr (2024) Nanobodies: a promising approach to treatment of viral diseases. Front Immunol 14:1303353","journal-title":"Front Immunol"},{"issue":"5","key":"1303_CR67","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001731","volume":"103","author":"A Moliner-Morro","year":"2022","unstructured":"Moliner-Morro A, McInerney GM, Hanke L (2022) Nanobodies in the limelight: multifunctional tools in the fight against viruses. J Gen Virol 103(5):001731","journal-title":"J Gen Virol"},{"issue":"45","key":"1303_CR68","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.1016\/j.vaccine.2021.08.010","volume":"39","author":"KA Moore","year":"2021","unstructured":"Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH et al (2021) A Research and Development (R&D) roadmap for influenza vaccines: looking toward the future. Vaccine 39(45):6573\u20136584","journal-title":"Vaccine"},{"issue":"4","key":"1303_CR69","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/molecules26040880","volume":"26","author":"SE Mtambo","year":"2021","unstructured":"Mtambo SE, Amoako DG, Somboro AM, Agoni C, Lawal MM, Gumede NS et al (2021) Influenza viruses: harnessing the crucial role of the M2 ion-channel and neuraminidase toward inhibitor design. Molecules 26(4):880","journal-title":"Molecules"},{"key":"1303_CR70","doi-asserted-by":"publisher","unstructured":"Mustafa MI, Mohammed A. Nanobodies as Spray and Aerosol Particles: A Breakthrough in Treating Respiratory Viral Infections [Preprint]. Preprints.org; 2023 Oct 18. https:\/\/doi.org\/10.20944\/preprints202310.1097.v1","DOI":"10.20944\/preprints202310.1097.v1"},{"issue":"1","key":"1303_CR71","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans S (2013) Nanobodies: natural single-domain antibodies. Annu Rev Biochem 82(1):775\u2013797","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"1303_CR72","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1111\/febs.15515","volume":"288","author":"S Muyldermans","year":"2021","unstructured":"Muyldermans S (2021) A guide to: generation and design of nanobodies. FEBS J 288(7):2084\u20132102","journal-title":"FEBS J"},{"issue":"3","key":"1303_CR73","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/vaccines8030382","volume":"8","author":"S Nath Neerukonda","year":"2020","unstructured":"Nath Neerukonda S, Vassell R, Weiss CD (2020) Neutralizing antibodies targeting the conserved stem region of influenza hemagglutinin. Vaccines 8(3):382","journal-title":"Vaccines"},{"key":"1303_CR74","doi-asserted-by":"publisher","unstructured":"Nayak DP, Baluda MA. Characterization of influenza virus ribonucleic acid duplex produced by annealing in vitro. J Virol. 1969 Sep;3(3):318\u201325. https:\/\/doi.org\/10.1128\/JVI.3.3.318-325.1969.","DOI":"10.1128\/JVI.3.3.318-325.1969"},{"key":"1303_CR75","unstructured":"Nguyen JVMH. Developing VHH-based tools to study Ebolavirus infection [dissertation]. Cambridge (MA): Massachusetts Institute of Technology; 2019"},{"key":"1303_CR76","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3389\/fmicb.2019.02862","volume":"10","author":"A Nogales","year":"2019","unstructured":"Nogales A, Aydillo T, \u00c1vila-P\u00e9rez G, Escalera A, Chiem K, Cadagan R et al (2019) Functional characterization and direct comparison of influenza A, B, C, and D NS1 proteins in vitro and in vivo. Front Microbiol 10:2862","journal-title":"Front Microbiol"},{"issue":"4","key":"1303_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.32607\/actanaturae.11495","volume":"13","author":"P Olga","year":"2021","unstructured":"Olga P (2021) Development of neutralizing nanobodies to the hemagglutinin stem domain of influenza A viruses. Acta Naturae (a\u043d\u0433\u043bo\u044f\u0437\u044b\u0447\u043da\u044f \u0412epc\u0438\u044f) 13(4):33\u201341","journal-title":"Acta Naturae (a\u043d\u0433\u043bo\u044f\u0437\u044b\u0447\u043da\u044f \u0412epc\u0438\u044f)"},{"key":"1303_CR78","unstructured":"Pan American Health Organization. . Epidemiological alert: Influenza \u2013 overview [PDF]. 2025. https:\/\/www.paho.org\/sites\/default\/files\/2025-01\/2025-jan-17-phe-alert-flu-ovr-he-norenfinal.pdf (Accessed July 20, 2025)."},{"issue":"3","key":"1303_CR79","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5114\/bta.2021.108724","volume":"102","author":"A Pedre\u00e1\u00f1ez","year":"2021","unstructured":"Pedre\u00e1\u00f1ez A, Mosquera-Sulbar\u00e1n J, Mu\u00f1\u00f3z N, Tene D, Robalino J (2021) Nanoantibodies: small molecules, big possibilities. Biotechnologia 102(3):321","journal-title":"Biotechnologia"},{"issue":"1","key":"1303_CR80","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/13880209.2024.2354341","volume":"62","author":"J Peng","year":"2024","unstructured":"Peng J, Ge C, Shang K, Liu S, Jiang Y (2024) Comprehensive profiling of the chemical constituents in Dayuanyin decoction using UPLC-QTOF-MS combined with molecular networking. Pharm Biol 62(1):480\u2013498","journal-title":"Pharm Biol"},{"key":"1303_CR81","doi-asserted-by":"crossref","unstructured":"Peteranderl C, Herold S, Schmoldt C (ed) (2016) Human influenza virus infections. Seminars in respiratory and critical care medicine. Thieme Medical Publishers","DOI":"10.1055\/s-0036-1584801"},{"issue":"6","key":"1303_CR82","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3343\/alm.2021.41.6.549","volume":"41","author":"TS Pillay","year":"2021","unstructured":"Pillay TS, Muyldermans S (2021) Application of single-domain antibodies (\u201cnanobodies\u201d) to laboratory diagnosis. Ann Lab Med 41(6):549\u2013558","journal-title":"Ann Lab Med"},{"key":"1303_CR83","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00216-019-01633-4","volume":"411","author":"J-P Salvador","year":"2019","unstructured":"Salvador J-P, Vilaplana L, Marco M-P (2019) Nanobody: outstanding features for diagnostic and therapeutic applications. Anal Bioanal Chem 411:1703\u20131713","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"1303_CR84","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","volume":"98","author":"M Samson","year":"2013","unstructured":"Samson M, Pizzorno A, Abed Y, Boivin G (2013) Influenza virus resistance to neuraminidase inhibitors. Antiviral Res 98(2):174\u2013185","journal-title":"Antiviral Res"},{"issue":"2","key":"1303_CR85","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/vaccines9020125","volume":"9","author":"M Sangesland","year":"2021","unstructured":"Sangesland M, Lingwood D (2021) Antibody focusing to conserved sites of vulnerability: the immunological pathways for \u2018universal\u2019 influenza vaccines. Vaccines 9(2):125","journal-title":"Vaccines"},{"issue":"8","key":"1303_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.80","volume":"1","author":"FI Schmidt","year":"2016","unstructured":"Schmidt FI, Hanke L, Morin B, Brewer R, Brusic V, Whelan SP et al (2016) Phenotypic lentivirus screens to identify functional single domain antibodies. Nat Microbiol 1(8):1\u201310","journal-title":"Nat Microbiol"},{"key":"1303_CR87","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0065-3527(05)64012-2","volume":"64","author":"AP Schmitt","year":"2005","unstructured":"Schmitt AP, Lamb RA (2005) Influenza virus assembly and budding at the viral budozone. Adv Virus Res 64:383\u2013416","journal-title":"Adv Virus Res"},{"issue":"7","key":"1303_CR88","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1462-5822.2010.01475.x","volume":"12","author":"M Schmolke","year":"2010","unstructured":"Schmolke M, Garc\u00eda-Sastre A (2010) Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 12(7):873\u2013880","journal-title":"Cell Microbiol"},{"issue":"6523","key":"1303_CR89","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.abe3255","volume":"370","author":"M Schoof","year":"2020","unstructured":"Schoof M, Faust B, Saunders RA, Sangwan S, Rezelj V, Hoppe N et al (2020) An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science 370(6523):1473\u20131479","journal-title":"Science"},{"issue":"21","key":"1303_CR90","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1016\/j.jmb.2019.03.018","volume":"431","author":"M Shafiuddin","year":"2019","unstructured":"Shafiuddin M, Boon AC (2019) RNA sequence features are at the core of influenza a virus genome packaging. J Mol Biol 431(21):4217\u20134228","journal-title":"J Mol Biol"},{"issue":"9","key":"1303_CR91","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/microorganisms9091956","volume":"9","author":"N Silva-Pilipich","year":"2021","unstructured":"Silva-Pilipich N, Smerdou C, Vanrell L (2021) A small virus to deliver small antibodies: new targeted therapies based on AAV delivery of nanobodies. Microorganisms 9(9):1956","journal-title":"Microorganisms"},{"issue":"1","key":"1303_CR92","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69(1):531\u2013569","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"1303_CR93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2217\/fvl-2019-0167","volume":"15","author":"P Sroga","year":"2020","unstructured":"Sroga P, Safronetz D, Stein DR (2020) Nanobodies: a new approach for the diagnosis and treatment of viral infectious diseases. Futur Virol 15(3):195\u2013205","journal-title":"Futur Virol"},{"issue":"7","key":"1303_CR94","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","volume":"21","author":"S Steeland","year":"2016","unstructured":"Steeland S, Vandenbroucke RE, Libert C (2016) Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discovery Today 21(7):1076\u20131113","journal-title":"Drug Discovery Today"},{"key":"1303_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101207","volume":"53","author":"X Sun","year":"2022","unstructured":"Sun X, Ling Z, Yang Z, Sun B (2022) Broad neutralizing antibody-based strategies to tackle influenza. Curr Opin Virol 53:101207","journal-title":"Curr Opin Virol"},{"key":"1303_CR96","doi-asserted-by":"crossref","unstructured":"Sun W, Wu Y, Ying T (2024) Progress in novel delivery technologies to improve efficacy of therapeutic antibodies.\u00a0Antivir Res 105867","DOI":"10.1016\/j.antiviral.2024.105867"},{"issue":"2","key":"1303_CR97","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1172\/JCI123366","volume":"129","author":"HX Tan","year":"2019","unstructured":"Tan HX, Jegaskanda S, Juno JA, Esterbauer R, Wong J, Kelly HG et al (2019) Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest 129(2):850\u2013862","journal-title":"J Clin Invest"},{"issue":"5","key":"1303_CR98","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41579-020-00501-8","volume":"19","author":"AJ Te Velthuis","year":"2021","unstructured":"Te Velthuis AJ, Grimes JM, Fodor E (2021) Structural insights into RNA polymerases of negative-sense RNA viruses. Nat Rev Microbiol 19(5):303\u2013318","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"1303_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004902","volume":"10","author":"S Terryn","year":"2016","unstructured":"Terryn S, Francart A, Rommelaere H, Stortelers C, Van Gucht S (2016) Post-exposure treatment with anti-rabies VHH and vaccine significantly improves protection of mice from lethal rabies infection. PLoS Negl Trop Dis 10(8):e0004902","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1303_CR100","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.antiviral.2012.12.014","volume":"97","author":"SV Tillib","year":"2013","unstructured":"Tillib SV, Ivanova TI, Vasilev LA, Rutovskaya MV, Saakyan SA, Gribova IY et al (2013) Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2). Antiviral Res 97(3):245\u2013254","journal-title":"Antiviral Res"},{"issue":"3","key":"1303_CR101","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1128\/jvi.64.3.1375-1377.1990","volume":"64","author":"JJ Treanor","year":"1990","unstructured":"Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR (1990) Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 64(3):1375\u20131377","journal-title":"J Virol"},{"issue":"1","key":"1303_CR102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/JCI44947","volume":"121","author":"DM Tscherne","year":"2011","unstructured":"Tscherne DM, Garcia-Sastre A (2011) Virulence determinants of pandemic influenza viruses. J Clin Investig 121(1):6\u201313","journal-title":"J Clin Investig"},{"key":"1303_CR103","unstructured":"Tung Yep AD (2023) Increasing the breadth and potency of a neutralising single domain antibody against the influenza haemagglutinin stem: UCL (University College London)"},{"issue":"3","key":"1303_CR104","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/biom11030407","volume":"11","author":"A Tung Yep","year":"2021","unstructured":"Tung Yep A, Takeuchi Y, Engelhardt OG, Hufton SE (2021) Broad reactivity single domain antibodies against influenza virus and their applications to vaccine potency testing and immunotherapy. Biomolecules 11(3):407","journal-title":"Biomolecules"},{"issue":"3","key":"1303_CR105","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.antiviral.2012.12.021","volume":"97","author":"IL Tutykhina","year":"2013","unstructured":"Tutykhina IL, Sedova ES, Gribova IY, Ivanova TI, Vasilev LA, Rutovskaya MV et al (2013) Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection. Antiviral Res 97(3):318\u2013328","journal-title":"Antiviral Res"},{"key":"1303_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2016.06.012","volume":"169","author":"G Van Heeke","year":"2017","unstructured":"Van Heeke G, Allosery K, De Brabandere V, De Smedt T, Detalle L, de Fougerolles A (2017) Nanobodies\u00ae as inhaled biotherapeutics for lung diseases. Pharmacol Ther 169:47\u201356","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1303_CR107","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.antiviral.2011.09.002","volume":"92","author":"P Vanlandschoot","year":"2011","unstructured":"Vanlandschoot P, Stortelers C, Beirnaert E, Iba\u00f1ez LI, Schepens B, Depla E et al (2011) Nanobodies\u00ae: new ammunition to battle viruses. Antiviral Res 92(3):389\u2013407","journal-title":"Antiviral Res"},{"issue":"2","key":"1303_CR108","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/v10020076","volume":"10","author":"S Venkataraman","year":"2018","unstructured":"Venkataraman S, Prasad BV, Selvarajan R (2018) RNA dependent RNA polymerases: insights from structure, function and evolution. Viruses 10(2):76","journal-title":"Viruses"},{"key":"1303_CR109","doi-asserted-by":"crossref","unstructured":"Verma V, Sinha N, Raja A (ed) (2025) Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics. mAbs. Taylor & Francis","DOI":"10.1080\/19420862.2025.2486390"},{"key":"1303_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2022.114871","volume":"657","author":"M Wang","year":"2022","unstructured":"Wang M, Wei L, Xiang H, Ren B, Liu X, Jiang L et al (2022) A megadiverse naive library derived from numerous camelids for efficient and rapid development of vhh antibodies. Anal Biochem 657:114871","journal-title":"Anal Biochem"},{"issue":"3","key":"1303_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.715","volume":"6","author":"W Wang","year":"2025","unstructured":"Wang W, Wang J, Hu Z, Yan X, Gao Q, Li X et al (2025) Advancing aggregation-induced emission-derived biomaterials in viral, tuberculosis, and fungal infectious diseases. Aggregate 6(3):e715","journal-title":"Aggregate"},{"issue":"1","key":"1303_CR112","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1038\/s41598-017-10021-w","volume":"7","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Ishikawa T, Otaki H, Mizuta S, Hamada T, Nakagaki T et al (2017) Structure-based drug discovery for combating influenza virus by targeting the PA\u2013PB1 interaction. Sci Rep 7(1):9500","journal-title":"Sci Rep"},{"issue":"12","key":"1303_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028309","volume":"6","author":"G Wei","year":"2011","unstructured":"Wei G, Meng W, Guo H, Pan W, Liu J, Peng T et al (2011) Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein. PLoS ONE 6(12):e28309","journal-title":"PLoS ONE"},{"issue":"3","key":"1303_CR114","first-page":"77","volume":"7","author":"RA Weiss","year":"2019","unstructured":"Weiss RA, Verrips CT (2019) Nanobodies That Neutralize HIV Vaccines 7(3):77","journal-title":"Nanobodies That Neutralize HIV Vaccines"},{"key":"1303_CR115","unstructured":"World Health Organization. Influenza Update N\u00b0 525 [Internet]. 2025 May 7 [cited 2025 Jul 20]. Available from: https:\/\/www.who.int\/publications\/m\/item\/influenza-update-n--525."},{"key":"1303_CR116","doi-asserted-by":"crossref","unstructured":"Williams JA, Gui L, Hom N, Mileant A, Lee KK (2018) Dissection of epitope-specific mechanisms of neutralization of influenza virus by intact IgG and Fab fragments. J Virol 92(6):10.1128\/jvi. 02006-17","DOI":"10.1128\/JVI.02006-17"},{"key":"1303_CR117","doi-asserted-by":"crossref","unstructured":"Wolff T, Veit M. Influenza B, C and D viruses (Orthomyxoviridae). In: Bamford DH, Zuckerman M, editors. Encyclopedia of Virology. 4th ed. Oxford: Elsevier; 2021. p. 561\u2013574","DOI":"10.1016\/B978-0-12-809633-8.21505-7"},{"issue":"8","key":"1303_CR118","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038778","volume":"10","author":"NC Wu","year":"2020","unstructured":"Wu NC, Wilson IA (2020) Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb Perspect Med 10(8):a038778","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1303_CR119","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3389\/fimmu.2017.01802","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Jiang S, Ying T (2017) Single-domain antibodies as therapeutics against human viral diseases. Front Immunol 8:1802","journal-title":"Front Immunol"},{"key":"1303_CR120","doi-asserted-by":"crossref","unstructured":"Yin D, Zhong Y, Ling S, Lu S, Wang X, Jiang Z et al (2024) Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers.\u00a0Nat Biomed Eng 1\u201316","DOI":"10.1038\/s41551-024-01208-4"},{"key":"1303_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101692","volume":"55","author":"H Zare","year":"2021","unstructured":"Zare H, Aghamollaei H, Hosseindokht M, Heiat M, Razei A, Bakherad H (2021) Nanobodies, the potent agents to detect and treat the Coronavirus infections: A systematic review. Mol Cell Probes 55:101692","journal-title":"Mol Cell Probes"},{"key":"1303_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111122","volume":"399","author":"L Zhao","year":"2024","unstructured":"Zhao L, Liao M, Li L, Chen L, Zhang T, Li R (2024) Cadmium activates the innate immune system through the AIM2 inflammasome. Chem Biol Interact 399:111122","journal-title":"Chem Biol Interact"},{"issue":"14","key":"1303_CR123","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMc070359","volume":"357","author":"B Zhou","year":"2007","unstructured":"Zhou B, Zhong N, Guan Y (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357(14):1450\u20131451","journal-title":"N Engl J Med"},{"issue":"8","key":"1303_CR124","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13835","volume":"33","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li L, Yu Z, Gu X, Pan R, Li Q et al (2022a) Dermatophagoides pteronyssinus allergen Der p 22: cloning, expression, IgE-binding in asthmatic children, and immunogenicity. Pediatr Allergy Immunol 33(8):e13835","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"1303_CR125","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/all.15111","volume":"77","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li Q, Pan R, Wang Q, Zhu X, Yuan C et al (2022b) Regulatory roles of three miRNAs on allergen mRNA expression in Tyrophagus putrescentiae. Allergy 77(2):469\u2013482","journal-title":"Allergy"},{"issue":"1","key":"1303_CR126","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1038\/s41467-024-51414-6","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L, Huang B, Wang X, Ni F, Ao M, Wang R et al (2024) Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nat Commun 15(1):6961","journal-title":"Nat Commun"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01303-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:03:30Z","timestamp":1758992610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01303-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01303-2","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"type":"print","value":"0015-5632"},{"type":"electronic","value":"1874-9356"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}